Digirad is UNDERVALUED at 4.07 per share with modest projections ahead. About 25.0% of Digirad shares are held by
institutions such as insurance companies. Insiders ownership of Digirad refers to the amount of Digirad equity owned by Digirad officers, directors, relatives of the leadership team, or anyone who has access to private information before it's made available to the public. Check out our latest analysis of Digirad, including its current
ownership diagnostics.
How important is Star Equity's Liquidity
Star Equity
financial leverage refers to using borrowed capital as a funding source to finance Star Equity Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Star Equity financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Star Equity's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Star Equity's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Star Equity's total debt and its cash.
Breaking down Star Equity Indicators
Digirad is displaying above-average volatility over the selected time horizon. Investors should scrutinize Digirad independently to ensure intended market timing strategies are aligned with expectations about Digirad volatility.
Returns Breakdown
| Return on Assets | (0.0728) |
| Return on Equity | (0.24) |
| Return Capital | (0.0777) |
| Return on Sales | (0.0367) |
Time to quit on of Digirad?
Latest coefficient of variation is at 1242.0. Digirad is displaying above-average volatility over the selected time horizon. Investors should scrutinize Digirad independently to ensure intended market timing strategies are aligned with expectations about Digirad volatility.
Our Conclusion on Digirad
Although many of the other players under the medical devices industry are still a bit expensive, Digirad may offer a potential longer-term growth to shareholders. With a relatively neutral outlook on the latest economy, it is better to hold off any trading of Digirad as the current risk-reward utility is not appealing enough. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Digirad.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Star Equity Holdings. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com